Administration of Angiotensin-Converting Enzyme Inhibitors and β-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?

BACKGROUND. Adjuvant trastuzumab therapy improves the outcome of patients with early breast cancer (EBC) and overexpression of human epidermal growth factor receptor 2 (HER2). However, it is potentially cardiotoxic. This study aims to evaluate the relationship between the use of angiotensin-converti...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Oliva, Stefano, Cioffi, Giovanni, Frattini, Silvia, Simoncini, Edda Lucia, Faggiano, Pompilio, Boccardi, Lidia, Pulignano, Giovanni, Fioretti, Agnese Maria, Giotta, Francesco, Lestuzzi, Chiara, Maurea, Nicola, Sabatini, Silvia, Tarantini, Luigi
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2012
Fag:
Breast Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399646/
https://ncbi.nlm.nih.gov/pubmed/22673631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0445
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker